Psychosocial intervention to improve cognitive and depression outcomes in older adults with mild cognitive impairment and early Alzheimer's disease
Official title: PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults With MCI and Early Stage AD
Run by Weill Medical College of Cornell University · NCT05081596 · Data updated 2026-11-12
This study is testing a new therapy to see if it can help older adults with mild cognitive impairment or early Alzheimer's disease feel better mentally and manage their pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (White Plains, New York) |
| Status | Recruiting |
| Started | June 3, 2022 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT05081596 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults aged 60 and above with a diagnosis of MCI or early-stage AD, experiencing chronic pain and mild depressive symptoms.
✕Probably not a fit
Patients with significant suicide risk or those deemed medically or neurologically unstable may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial examines the effects of Problem Adaptation Therapy for Pain (PATH-Pain) on cognitive functioning, depression, and pain-related disability in older adults diagnosed with mild cognitive impairment (MCI) or early-stage Alzheimer's disease (AD). The study involves a randomized control trial design, where participants will receive either PATH-Pain or Attention Control Usual Care over a series of therapy sessions. The intervention consists of 8 in-office sessions followed by 6 telephone sessions, focusing on improving cognitive, affective, and functional outcomes. Assessments will be conducted at various intervals to evaluate the efficacy of the intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cognitive function and reduce depression and pain-related disability in older adults with MCI and early-stage AD.
How similar studies have gone: Other studies have shown promise in using psychosocial interventions for cognitive and emotional outcomes in similar populations, suggesting a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 60 years old * MCI or early stage probable or possible AD diagnosis (as defined by Albert et al or McKhann et al) al). Patients will have at least mild cognitive deficits defined by 16 ≤ MoCA ≤ 25. * Montgomery Asberg Depression Rating Scale (MADRS)\[55\] total ≥ 5, which reflects at least some mild depressive symptoms. * Participants will be off antidepressants, cholinesterase inhibitors or memantine or on a stable dosage for at least 12 weeks. * Chronic pain (neuropathic, nociceptive or mixed disorders): presence of pain on most days for at least 3 months and average pain intensity score \>=4. * Clinical Dementia Rating 0.5 ≤ (CDR) ≤ 1. * Participant will have capacity to consent. * Participation of a study partner (e.g. caregiver/family member/significant other) is required. Exclusion Criteria: * Deemed to have a significant suicide risk as assessed by site PI and clinical team. * Deemed too unstable medically or neurologically to safely enroll in a research trial. * Deemed too psychiatrically unstable to safely enroll in randomized trial of psychotherapy. * Requiring psychiatric hospitalization at baseline for safety. * Lack of English fluency.
Where it's running
-
Weill Cornell Medicine
White Plains, New York, United States Recruiting
Study contacts
- Principal investigator: Dimitris Kiosses, PhD — Weill Medical College of Cornell University
- Study coordinator: Dimtiris Kiosses, PhD
- Email: dkiosses@med.cornell.edu
- Phone: 914-997-4381
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of Transcutaneous Vagal Nerve Stimulation on Return to Consciousness After Surgery
This study tests whether noninvasive tcVNS can help people wake up faster after surgery and reduce delirium and depression in the recovery period.
-
Assessing visual frailty in older adults with age-related macular degeneration
This study is trying to see if a new tool can help understand how vision problems affect older adults with advanced age-related macular degeneration and their overall health.
-
Investigating brain activity during cognitive tasks
This study is testing how brain activity changes during thinking and memory tasks in people who need surgery, to help find better treatments for cognitive issues like dementia and attention disorders.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.